AzTrials
AzTrials

Acute Abdominal PainIRMADANCT03281031

MRI as an Alternative to CT for Exploration of Acute Abdominal Pain in Young Women

A study testing Additional MRI Examination in people with Acute Abdominal Pain and Pelvic Pain, run by University Hospital, Montpellier at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Objective : To demonstrate diagnostic performances of Magnetic Resonance Imaging (MRI) as compared to Computed Tomography (CT) as a second intention imaging modality in young women with acute non traumatic abdominopelvic pain and non contributive ultrasonography. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Acute Abdominal Pain, Pelvic Pain
What is being tested?
Additional MRI Examination
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
149 participants
Where
1 siteFrance
Study dates
18 Oct 2017to 19 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women aged 18-40 years old
  • Women referred to CT following a non contributive ultrasonography
  • Women with acute non traumatic abdominopelvic pain (less than 5 day-duration)
  • Women with informed consent
  • Women with affiliation to health insurance

Who cannot join

  • Women who underwent abdominopelvic surgery in the previous month
  • Suspicion of vital emergency such as shock preventing any delayed management caused by MRI examination
  • Contra-indication to MRI, including pace maker, ferro-magnetic material, foreign bodies with risk of mobilization during MRI examination
  • Women yet included in the study or included in another study
  • Women pregnant (positive beta chorionic gonadotrophic hormone testing) or breastfeeding
  • Women unable to undergo informed consent (vulnerable or protected by law)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Departement of Medical Imaging

    Montpellier, 34295

Other trials in France

About this study

Official title: Diagnostic Performance of MRI as an Alternative to CT Following a Non-diagnostic Ultrasonography in Young Women With Acute/Subacute Abdominal Pain : a Prospective Multicenter Study

Objective :

To demonstrate diagnostic performances of Magnetic Resonance Imaging (MRI) as compared to Computed Tomography (CT) as a second intention imaging modality in young women with acute non traumatic abdominopelvic pain and non contributive ultrasonography.

Read the detailed description

Methods :

Consecutive women aged 18-40 years old with acute abdominopelvic pain referred to CT by the emergency Physician or gynaecologist after a non contributive ultrasonography will be included.

After obtaining informed consent, all patients will undergo standard CT followed by an additional MRI examination, performed using a short MRI protocol and within 6 hour from CT.

The gold standard or reference diagnosis will be established in consensus by an expert panel at 3 months follow up using a standardized diagnosis form.

A retrospective reading will be performed independently for CT and MRI by radiologists blinded to the reference diagnosis, using the same standardized diagnosis form.

CT and MRI accuracies will be compared.

Being tested
Additional MRI Examination
Keywords
MRI, Acute abdominal pain, Pelvic pain, Diagnostic performance, Young women
Medical subject headings
Abdomen, Acute, Pelvic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Additional MRI ExaminationProcedure or surgery

    MRI will be performed using a short protocol within 6 hours from CT and with blinding from CT results

Study groups in NCT03281031
Study groupRoleWhat they receive
Additional MRI ExaminationOtherSingle arm, all patient will undergo CT followed by additional MRI examination
Receives: Procedure: Additional MRI Examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic performances comparison between CT and MRI

    Diagnostic performances (sensitivity, specificity, predictive values) comparison between CT and MRI

    Measured: 3 months

Secondary outcomes (3)
  1. Diagnostic performances of a conditional imaging strategy including first MRI for all cases and CT in cases where MRI is non contributive

    Diagnostic performances (sensitivity, specificity and predictive values) of a conditional imaging strategy including first MRI for all cases and CT in cases where MRI is non contributive (strategy built retrospectively)

    Measured: 3 months

  2. Diagnostic performances of unenhanced MRI sequences versus complete MRI examination

    Diagnostic performances (sensitivity, specificity and predictive values) of unenhanced MRI sequences versus complete MRI examination (including both unenhanced and enhanced sequences)

    Measured: 3 months

  3. Inter-reader agreement for MRI and CT diagnoses

    Inter-reader agreement (Kappa statistics) for MRI and CT diagnoses (retrospective reading)

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2017
  2. Study start18 Oct 2017
  3. Primary completion19 Dec 2022
  4. Study completion19 Dec 2022

Why it stopped: Logistical constraints at the centers

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
149 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03281031
Sponsor's protocol ID
UF9803
Other IDs
2017-A00725-48
Acronym
IRMADA
Status last verified
May 2026
First submitted
27 Jul 2017
Last updated
15 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Charret O, Fournier L, Poncelet E, Duraes M, Bobbia X, Bazot M, Beranger S, Chaumoitre K, Arcis E, Rousset P, Coutureau J, Fillias Q, Delebecq J, Pages-Bouic E, Molinari N, Nogue E, Taourel P, Millet I. MRI as an alternative to CT after inconclusive ultrasound in subacute/acute abdominal pain in young women: a prospective multicenter noninferiority study. Eur Radiol. 2025 Nov;35(11):6642-6654. doi: 10.1007/s00330-025-11629-7. Epub 2025 Apr 30.

    PubMed 40307528

Questions about this trial

What is this clinical trial studying?

A study testing Additional MRI Examination in people with Acute Abdominal Pain and Pelvic Pain, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 15 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Logistical constraints at the centers). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic performances comparison between CT and MRI (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03281031, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in